BioHealth News Archive
FDA Commissioner Says Panel Must Review COVID Vaccine
JOHN WHYTE: You're watching "Coronavirus in Context." I'm Dr. John Whyte, chief medical officer at WebMD. Today I'm joined by Dr. Stephen Hahn. He's…
Read More
Trump Administration Expands Collaboration With AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19 > U.S. DEPARTMENT OF DEFENSE > Release
To meet the Trump Administration’s Operation Warp Speed goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) today…
Read More
Can culture and community drive success? – Research & Development World
Not every research project succeeds. And not every company survives. However, the ones that align with the culture of winning and sign up and…
Read More
Montgomery County Executive Marc Elrich joins Rich Bendis on BioTalk
Montgomery County Executive Marc Elrich joins BioTalk to discuss his Career Path, the BioHealth Industry and plans to support the Industry in MoCo. Listen…
Read More
Justin Yang, Biomedical Advanced Research and Development Authority (BARDA) Director of the DRIVe Catalyst Office, Joins Rich Bendis on BioTalk
BARDA Director of the DRIVe Catalyst Office, Justin Yang, Joins BioTalk to share how BARDA collaborates with the BioHealth Industry, partners with Incubators, and…
Read More
How This Med Tech Startup Pivoted to Fight the Pandemic
Across the world in 2019, UNICEF reports that over 2.4 million infants died in their first month of life, the vast majority in the…
Read More
Children’s National Hospital earns 2020 CHIME Digital Health Most Wired recognition | Children’s National Hospital
Children’s National Hospital has received 2020 Digital Health Most Wired recognition by The College of Healthcare Information Management Executives (CHIME) as a certified level…
Read More
FDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease – BioHealth Capital Region
ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 5, 2020– GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation…
Read More
The unsung mapmakers | Hub
In the early days of managing the Johns Hopkins COVID-19 dashboard, experts at the university and those at Esri, the company providing the mapping…
Read More
Life Sciences Go Viral in Maryland
When Maryland Gov. Larry Hogan visited Novavax recently, President and CEO Stanley C. Erck shared some welcome news for the governor publicly: Novavax had…
Read More
Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research – COVID-19 – Hospimedica.com
QIAGEN N.V. (Venlo, Netherlands) plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and…
Read MoreBaltimore venture capital firm Catalio Capital Management closes $100M fund – Baltimore Business Journal
Catalio's portfolio includes many notable local biotech companies, including Personal Genome Diagnostics Inc. and Thrive Earlier Detection Corp. Image: George Petrocheilos (right) and R.…
Read More
First Patient Dosed in NexImmune Phase 1/2 Clinical Trial of NEXI-002 in Multiple Myeloma
GAITHERSBURG, MD -- October 6, 2020 – NexImmune, a clinical-stage biotechnology company developing a portfolio of unique non-genetically-engineered T cell immunotherapies, announced today that…
Read More
This Maryland program will pair cyber researchers and entrepreneurial grad students to form startups – Technical.ly Baltimore
Maryland universities are home to lots of cyber researchers and technologists working on new ways to secure our increasingly technology-reliant society. Those higher education…
Read More
Pipeline – Immunomic Therapeutics
Our allergy assets remain an underpinning of Immunomic Therapeutics’ success, and have enabled our pivot to focus on oncology. In addition to our canine atopic dermatitis…
Read More